Brief: Glenmark Pharma Launches Vancomycin Hydrochloride For Injection USP, 500 Mg/Vial And 1 G/Vial
18/05/2026 04:28
May 18 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMA - LAUNCHES VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP, 500 MG/VIAL AND 1 G/VIAL Source text: ID:nBSE93bDRP Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter